Home ETF List About

Portfolio Holdings Detail for ISIN IE000D8XC064
Stock Name / FundiShares World Equity Enhanced Active UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWOEE(GBP) LSE
ETF TickerWOEE.AS(USD) AS
ETF TickerWOEE.AS(USD) Euronext Amsterdam

Holdings detail for BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright
HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout
In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.
Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET
(RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.
Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares World Equity Enhanced Active UCITS ETF USD (Acc) BMRN holdings

DateNumber of BMRN Shares HeldBase Market Value of BMRN SharesLocal Market Value of BMRN SharesChange in BMRN Shares HeldChange in BMRN Base ValueCurrent Price per BMRN Share HeldPrevious Price per BMRN Share Held
2025-11-13 (Thursday)8,221USD 445,743USD 445,743
2025-11-12 (Wednesday)8,221USD 454,786BMRN holding increased by 3206USD 454,7860USD 3,206 USD 55.32 USD 54.9301
2025-11-11 (Tuesday)8,221USD 451,580BMRN holding increased by 18580USD 451,5800USD 18,580 USD 54.9301 USD 52.67
2025-11-10 (Monday)8,221BMRN holding decreased by -54USD 433,000BMRN holding increased by 7168USD 433,000-54USD 7,168 USD 52.67 USD 51.4601
2025-11-07 (Friday)8,275BMRN holding increased by 126USD 425,832BMRN holding increased by 3388USD 425,832126USD 3,388 USD 51.4601 USD 51.84
2025-11-06 (Thursday)8,149USD 422,444BMRN holding decreased by -7823USD 422,4440USD -7,823 USD 51.84 USD 52.8
2025-11-05 (Wednesday)8,149BMRN holding increased by 18USD 430,267BMRN holding increased by 3227USD 430,26718USD 3,227 USD 52.8 USD 52.52
2025-11-04 (Tuesday)8,131BMRN holding increased by 354USD 427,040BMRN holding increased by 16026USD 427,040354USD 16,026 USD 52.52 USD 52.8499
2025-11-03 (Monday)7,777USD 411,014BMRN holding decreased by -5600USD 411,0140USD -5,600 USD 52.8499 USD 53.57
2025-10-31 (Friday)7,777USD 416,614BMRN holding increased by 12910USD 416,6140USD 12,910 USD 53.57 USD 51.91
2025-10-30 (Thursday)7,777BMRN holding increased by 130USD 403,704BMRN holding increased by 7131USD 403,704130USD 7,131 USD 51.91 USD 51.8599
2025-10-29 (Wednesday)7,647BMRN holding increased by 270USD 396,573BMRN holding increased by 1977USD 396,573270USD 1,977 USD 51.8599 USD 53.49
2025-10-28 (Tuesday)7,377BMRN holding increased by 212USD 394,596BMRN holding increased by 17215USD 394,596212USD 17,215 USD 53.49 USD 52.6701
2025-10-27 (Monday)7,165BMRN holding increased by 84USD 377,381BMRN holding decreased by -8392USD 377,38184USD -8,392 USD 52.6701 USD 54.48
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE000D8XC064

Show aggregate share trades of BMRN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10SELL-5452.80051.810 51.909USD -2,803 60.73 Profit of 476 on sale
2025-11-07BUY12651.90050.760 50.874USD 6,410 60.79
2025-11-05BUY1853.49051.860 52.023USD 936 60.89
2025-11-04BUY35452.76051.800 51.896USD 18,371 60.95
2025-10-30BUY13052.48551.143 51.277USD 6,666 61.11
2025-10-29BUY27051.86054.750 54.461USD 14,704 61.17
2025-10-28BUY21253.49056.800 56.469USD 11,971 61.22
2025-10-27BUY8452.67055.840 55.523USD 4,664 61.28
2025-10-24BUY1854.48055.030 54.975USD 990 61.32
2025-10-20BUY61653.07053.550 53.502USD 32,957 61.53
2025-10-16BUY24652.95053.960 53.859USD 13,249 61.65
2025-10-15BUY25853.09053.760 53.693USD 13,853 61.71
2025-10-06BUY1255.61056.060 56.015USD 672 61.80
2025-10-03BUY10255.43056.000 55.943USD 5,706 61.85
2025-10-02BUY5455.57055.990 55.948USD 3,021 61.90
2025-08-12BUY16856.86057.460 57.400USD 9,643 62.10
2025-08-11BUY3056.80057.630 57.547USD 1,726 62.14
2025-08-04BUY1860.31060.630 60.598USD 1,091 62.19
2025-07-31SELL-32357.85059.010 58.894USD -19,023 62.26 Profit of 1,086 on sale
2025-07-22BUY2859.20059.220 59.218USD 1,658 62.36
2025-07-21BUY18956.56057.550 57.451USD 10,858 62.41
2025-07-17SELL-24758.37059.350 59.252USD -14,635 62.49 Profit of 799 on sale
2025-07-11BUY12058.10058.500 58.460USD 7,015 62.65
2025-07-10SELL-22058.82059.570 59.495USD -13,089 62.68 Profit of 701 on sale
2025-07-09BUY10059.67059.980 59.949USD 5,995 62.71
2025-06-30BUY8154.97055.960 55.861USD 4,525 62.92
2025-06-26BUY4054.10054.550 54.505USD 2,180 63.08
2025-06-25BUY17654.14054.610 54.563USD 9,603 63.16
2025-06-16BUY4056.24056.510 56.483USD 2,259 63.55
2025-06-13BUY4856.22057.360 57.246USD 2,748 63.62
2025-06-12BUY9057.28057.650 57.613USD 5,185 63.68
2025-06-11BUY43657.16057.990 57.907USD 25,247 63.75
2025-06-10BUY1857.48058.170 58.101USD 1,046 63.81
2025-06-06BUY3656.65057.810 57.694USD 2,077 63.96
2025-06-02BUY1857.05058.590 58.436USD 1,052 64.29
2025-05-28BUY4058.09059.120 59.017USD 2,361 64.50
2025-05-14BUY3258.70060.030 59.897USD 1,917 65.15
2025-05-13BUY1659.78061.300 61.148USD 978 65.22
2025-05-12BUY15261.37062.300 62.207USD 9,455 65.27
2025-04-30BUY19263.69064.000 63.969USD 12,282 65.76
2025-04-29BUY47263.28064.080 64.000USD 30,208 65.79
2025-04-28BUY862.98063.870 63.781USD 510 65.84
2025-04-24SELL-2462.74063.090 63.055USD -1,513 65.92 Profit of 69 on sale
2025-04-23BUY3261.94063.390 63.245USD 2,024 65.98
2025-04-17SELL-1659.17059.620 59.575USD -953 66.40 Profit of 109 on sale
2025-04-16BUY12058.82060.460 60.296USD 7,236 66.53
2025-04-15BUY5660.02060.930 60.839USD 3,407 66.64
2025-04-08BUY5655.89061.070 60.552USD 3,391 67.47
2025-04-07BUY38459.16060.610 60.465USD 23,219 67.63
2025-04-04BUY39260.26066.490 65.867USD 25,820 67.77
2025-04-01BUY7267.94070.630 70.361USD 5,066 67.75
2025-03-31BUY4870.69071.280 71.221USD 3,419 67.69
2025-03-28BUY7271.44072.810 72.673USD 5,232 67.62
2025-03-27BUY1672.83073.180 73.145USD 1,170 67.51
2025-03-26BUY10471.48071.920 71.876USD 7,475 67.42
2025-03-24BUY7271.99072.370 72.332USD 5,208 67.22
2025-03-19SELL-3271.32072.080 72.004USD -2,304 66.92 Loss of -163 on sale
2025-03-13SELL-3370.60071.930 71.797USD -2,369 66.50 Loss of -175 on sale
2025-03-12BUY2470.54070.820 70.792USD 1,699 66.39
2025-03-07BUY4072.23073.510 73.382USD 2,935 65.91
2025-02-28SELL-4871.16071.220 71.214USD -3,418 65.22 Loss of -288 on sale
2025-02-04BUY962.87063.530 63.464USD 571 64.02
2025-01-30BUY4763.88064.230 64.195USD 3,017 64.29
2025-01-29BUY2463.46064.050 63.991USD 1,536 64.39
2025-01-28BUY2463.25063.480 63.457USD 1,523 64.55
2025-01-27BUY20861.80063.150 63.015USD 13,107 65.01
2025-01-24BUY10461.73063.060 62.927USD 6,544 65.67
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19410,0268,500779,51352.6%
2025-09-18309,9349,272546,27156.7%
2025-09-17792,001761,198,91966.1%
2025-09-16481,50501,174,96941.0%
2025-09-15537,10968901,19259.6%
2025-09-12559,51941804,63869.5%
2025-09-11479,992858740,03264.9%
2025-09-10670,394301865,41977.5%
2025-09-09347,7870583,41259.6%
2025-09-08440,4270726,53560.6%
2025-09-05291,8700466,53662.6%
2025-09-04516,7790829,87862.3%
2025-09-03280,8020490,76857.2%
2025-09-02312,7570686,20245.6%
2025-08-29214,12613370,04357.9%
2025-08-28251,9167439,79557.3%
2025-08-27370,3496578,90564.0%
2025-08-26289,675233549,90452.7%
2025-08-25355,827100585,45360.8%
2025-08-22357,18416556,52864.2%
2025-08-21352,5011,525524,29367.2%
2025-08-20339,77774602,58956.4%
2025-08-19220,4370499,04144.2%
2025-08-18330,939435644,69651.3%
2025-08-15498,8220931,91353.5%
2025-08-14241,4360529,66845.6%
2025-08-13719,9923501,132,11263.6%
2025-08-12217,2424606,98935.8%
2025-08-11336,9850722,60446.6%
2025-08-08574,538391,320,70843.5%
2025-08-07387,50431837,24046.3%
2025-08-06571,71843896,31463.8%
2025-08-051,685,68712,5033,542,20047.6%
2025-08-041,579,75703,686,25742.9%
2025-08-01716,52602,200,77732.6%
2025-07-31549,45938925,08459.4%
2025-07-30718,573101,234,75558.2%
2025-07-29226,72575481,37547.1%
2025-07-28243,6265412,92959.0%
2025-07-25247,29586445,58755.5%
2025-07-24380,699137586,87264.9%
2025-07-23251,7130450,21955.9%
2025-07-22387,886114638,28360.8%
2025-07-21228,3756,803346,20866.0%
2025-07-18292,003100575,02850.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.